To further test the critical role of the Dex-mTOR signaling axis in colitis-associated cancer, we established a colitis-associated cancer mouse model by using the combined administration of the genotoxic agent azoxymethane (AOM) and DSS, as described in Figure 8a. This evidence concerns the gene MTOR and colitis.